Oseltamivir Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2020 - 2025

Report Code: HCR 25418 Report Format: PDF + Excel (Delivery in 48 Hrs)
Oseltamivir Market size is forecast to reach $694.3 million by 2025, growing at a CAGR of 3.17% during the forecast period 2020-2025. Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. It helps make the symptoms like stuffy nose, cough, sore throat, fever/chills, aches, and tiredness less severe and shortens the recovery time by 1-2 days. Oseltamivir acts as neuraminidase inhibitor of the influenza virus, by preventing its reproduction by budding from the host cell. This also prevents the cleavage of sialic acid residues, thus interfering with progeny virus disbursement within the mucosal secretions and reducing viral infectivity. Growing incidences of influenza among the population, increasing awareness about the prevention, and increasing investments in novel drug combinations by big investment firms are major factors that are driving the market growth in recent years. In addition, major developments by key market players like Alembic Pharmaceuticals are other factors driving the growth of the market. 

Report Coverage
The report: “Oseltamivir Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Oseltamivir Market. 

By Formulation: Capsule, Powder
By Indication: Influenza A, Influenza B
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Geography: North America, Europe, Asia-Pacific, Rest of the World (RoW)

Key Takeaways
  • North America dominated the Oseltamivir Market in the year 2019 owing to large number of cases of the population infected with influenza, increasing healthcare affordability of the majority population and government initiatives, presence of key market players in the region and funds for better innovations in the drug market. The Oseltamivir Market scope for different regions will be provided in the final report.
  • Rising numbers of influenza cases among the population, increasing awareness programs about the prevention and treatment of influenza, and increasing investments in novel drug combinations by big investment firms and key players in the market have helped in significant growth of Oseltamivir Market. 
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Oseltamivir Market report.
  • Side effects of Oseltamivir is anticipated to hamper the market growth of the Oseltamivir Industry.

Indication - Segment Analysis
Influenza A held the largest share in the indication segment of Oseltamivir Market in 2019 and is estimated to grow at a CAGR of 2.71% during the forecast period 2020-2025. Factors that contribute to the growth of this segment are the increasing prevalence of the disease and recent FDA approval of products by various companies for oral and other forms of dosage for influenza A. Also, spread of influenza A in other living beings (compared to influenza B which occurs only in human beings), and more severe reactions have led to demand for more and better medication by Oseltamivir drug, hence fueling market growth. Influenza B held the second largest share in the market, owing to a large percentage of influenza patients being affected by influenza B and more preference to Oseltamivir for its treatment. Influenza A segment is set to be the fastest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025, owing to major investments in medications for treatment of Influenza A by key market players.

Distribution Channels - Segment Analysis
Hospital Pharmacies segment held the major share in the distribution channels segment of Oseltamivir Market in 2019. Specialty drugs spend, next-door healthcare, increased focus on 340B performance and compliance, tracking and managing data and public policy with greater transparency are driving the market growth of this segment. Online Pharmacies segment is forecast to continue growing at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to growing trends in digital services and favorable government policies for online retails of medicines.

Geography - Segment Analysis
North America dominated the geography segment of Oseltamivir Market with a share of more than 37.41% in 2019, followed by Europe. Growing prevalence of influenza, increasing healthcare affordability of the masses and government initiatives for increasing awareness about prevention and treatment of influenza have helped in the growth of Oseltamivir Market infrastructure in this region. Europe held the second place in the geography segment share of the market, owing to presence of government guidelines for maintaining health of the population and presence of well-developed healthcare infrastructure.
However, Asia-Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025. This is owing to the growing drug market, gradually increasing awareness about the medications of influenza and entry of big investment firms in the region.

Drivers – Oseltamivir Market
  • Rising numbers of influenza cases among the population
The proportion of people who get sick from influenza has increased over the years. A survey report found that between 3% and 11% of the U.S. population gets infected and develops Influenza A or B each year. The 3% estimate is from the 2015-2016 season, which was an H1N1-predominant season classified as being of medium to high severity. With the growing statistics of the disease in the population at present, this is set to drive the market growth in the coming years.
  • Increasing awareness programs about Influenza
WHO/Europe launched the Flu Awareness Campaign initiative in 2013 as an extension of European Immunization Week. Influenza is usually mild and most people recover quickly. However, this contagious respiratory illness caused by influenza viruses occasionally cause severe disease and death. The best way to prevent influenza is by getting vaccinated. In order to make people aware, the campaigns serve the way for treatment with medications like Oseltamivir. As such, the market is poised to see significant growth during the forecast period 2020-2025.

Challenges – Oseltamivir Market
  • Side effects of Oseltamivir
Common side effects of Oseltamivir include nausea, vomiting, diarrhea, dizziness, headache, nosebleed, eye redness or discomfort and sleep problems (insomnia). This creates a negative impact on the demand of Oseltamivir among patients and buyers. Thus, it is anticipated to hamper the market growth during the forecast period 2020-2025.

Oseltamivir Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Oseltamivir Market. In 2019, Oseltamivir Market share is consolidated by the top players present in the market. Oseltamivir Market top 10 companies are Cipla Inc, Sanofi, Hetero Healthcare Ltd, Lotus International, Md Export, Nagar Medico, Alembic Pharmaceuticals, Shivam Pharma Export, Natco Pharma and Triveni Chemical, among others.

Acquisitions/Product Launches
  • In June 2019, the US Food and Drug Administration approved Alembic Pharmaceuticals’ abbreviated new drug application for Oseltamivir phosphate capsules USP, 30 mg, 45 mg, and 75 mg.
  • In July 2019, Sanofi signed strategic deal for exclusive US over-the-counter rights to Tamiflu in Flu Care.
  • In December 2016, Natco Pharma, and partner Alvogen launched the “first generic equivalent” of Roche's Tamiflu (Oseltamivir) in the U.S. The US FDA approved India based Natco Pharma and its US partner Alvogen's application for a generic of Tamiflu.
1. Oseltamivir Market Overview
    1.1 Definitions and Scope
2. Oseltamivir Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Formulation
    2.3 Key trends by Distribution Channel 
    2.4 Key trends by Geography
3. Oseltamivir Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Oseltamivir Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Oseltamivir Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Oseltamivir Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Oseltamivir Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Oseltamivir Market – By Formulation (Market Size –$Million/$Billion)
    8.1 Capsule
    8.2 Powder
9. Oseltamivir Market – By Indication (Market Size –$Million/$Billion)
    9.1 Influenza A
    9.2 Influenza B
10. Oseltamivir Market – By Distribution Channel (Market Size –$Million/$Billion)
    10.1 Hospital Pharmacies
    10.2 Retail Pharmacies
    10.3 Online Pharmacies
    10.4 Others
11. Oseltamivir Market – By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Oseltamivir Market - Entropy
13. Oseltamivir Market – Industry/Segment Competition Landscape   (Premium) 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Oseltamivir Market – Key Company List by Country Premium (Premium)
15. Oseltamivir Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Global Oseltamivir Market, By Formulation Market 2019-2024 ($M)
1.1 Capsule Market 2019-2024 ($M) - Global Industry Research
1.2 Powder Market 2019-2024 ($M) - Global Industry Research
2.Global Global Oseltamivir Market, By Formulation Market 2019-2024 (Volume/Units)
2.1 Capsule Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 Powder Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America Global Oseltamivir Market, By Formulation Market 2019-2024 ($M)
3.1 Capsule Market 2019-2024 ($M) - Regional Industry Research
3.2 Powder Market 2019-2024 ($M) - Regional Industry Research
4.South America Global Oseltamivir Market, By Formulation Market 2019-2024 ($M)
4.1 Capsule Market 2019-2024 ($M) - Regional Industry Research
4.2 Powder Market 2019-2024 ($M) - Regional Industry Research
5.Europe Global Oseltamivir Market, By Formulation Market 2019-2024 ($M)
5.1 Capsule Market 2019-2024 ($M) - Regional Industry Research
5.2 Powder Market 2019-2024 ($M) - Regional Industry Research
6.APAC Global Oseltamivir Market, By Formulation Market 2019-2024 ($M)
6.1 Capsule Market 2019-2024 ($M) - Regional Industry Research
6.2 Powder Market 2019-2024 ($M) - Regional Industry Research
7.MENA Global Oseltamivir Market, By Formulation Market 2019-2024 ($M)
7.1 Capsule Market 2019-2024 ($M) - Regional Industry Research
7.2 Powder Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Oseltamivir Market Revenue, 2019-2024 ($M)
2.Canada Oseltamivir Market Revenue, 2019-2024 ($M)
3.Mexico Oseltamivir Market Revenue, 2019-2024 ($M)
4.Brazil Oseltamivir Market Revenue, 2019-2024 ($M)
5.Argentina Oseltamivir Market Revenue, 2019-2024 ($M)
6.Peru Oseltamivir Market Revenue, 2019-2024 ($M)
7.Colombia Oseltamivir Market Revenue, 2019-2024 ($M)
8.Chile Oseltamivir Market Revenue, 2019-2024 ($M)
9.Rest of South America Oseltamivir Market Revenue, 2019-2024 ($M)
10.UK Oseltamivir Market Revenue, 2019-2024 ($M)
11.Germany Oseltamivir Market Revenue, 2019-2024 ($M)
12.France Oseltamivir Market Revenue, 2019-2024 ($M)
13.Italy Oseltamivir Market Revenue, 2019-2024 ($M)
14.Spain Oseltamivir Market Revenue, 2019-2024 ($M)
15.Rest of Europe Oseltamivir Market Revenue, 2019-2024 ($M)
16.China Oseltamivir Market Revenue, 2019-2024 ($M)
17.India Oseltamivir Market Revenue, 2019-2024 ($M)
18.Japan Oseltamivir Market Revenue, 2019-2024 ($M)
19.South Korea Oseltamivir Market Revenue, 2019-2024 ($M)
20.South Africa Oseltamivir Market Revenue, 2019-2024 ($M)
21.North America Oseltamivir By Application
22.South America Oseltamivir By Application
23.Europe Oseltamivir By Application
24.APAC Oseltamivir By Application
25.MENA Oseltamivir By Application
26.Triveni Chemical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Cipla Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Hetero Healthcare Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Nagar Medico, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Tissue Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Md Export, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Lotus International, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Shivam Pharma Export, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Cuidado Medico, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Nerium Pharmaceutical Export, Sales /Revenue, 2015-2018 ($Mn/$Bn)